Protagonist Therapeutics, Inc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Protagonist Therapeutics, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Protagonist Therapeutics, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $166M, a 20.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $166M +$28.1M +20.4% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $138M +$34.2M +32.9% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $104M +$32M +44.5% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $71.9M +$19.4M +36.9% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $52.5M +$18.5M +54.3% Dec 31, 2019 10-K 2021-03-10
Q4 2018 $34M +$8.15M +31.5% Dec 31, 2018 10-K 2020-03-10
Q4 2017 $25.9M +$1.92M +7.99% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $24M +$13.4M +127% Dec 31, 2016 10-K 2018-03-07
Q4 2015 $10.6M Dec 31, 2015 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.